| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1354205 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SPTLC2 mRNA | CTD | PMID:22079256 |
| 17beta-estradiol | increases expression | ISO | RGD:1614415 | 6480464 | Estradiol results in increased expression of SPTLC2 mRNA | CTD | PMID:15289156 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1614415 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SPTLC2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1354205 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SPTLC2 mRNA | CTD | PMID:23152189 |
| 2-acetamidofluorene | increases expression | ISO | RGD:1614415 | 6480464 | 2-Acetylaminofluorene results in increased expression of SPTLC2 mRNA | CTD | PMID:17317680 |
| 3-methylcholanthrene | multiple interactions | ISO | RGD:1354205 | 6480464 | Methylcholanthrene promotes the reaction [AHR protein binds to SPTLC2 promoter] | CTD | PMID:20348232 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1614415 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of SPTLC2 mRNA | CTD | PMID:18648102 |
| 8'-apo-beta,psi-caroten-8'-al | affects expression | ISO | RGD:1354205 | 6480464 | apocarotenal affects the expression of SPTLC2 mRNA | CTD | PMID:17034753 |
| aflatoxin B1 | decreases expression | ISO | RGD:1614415 | 6480464 | Aflatoxin B1 results in decreased expression of SPTLC2 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1614415 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of SPTLC2 mRNA | CTD | PMID:21715664 |
| beta-carotene | affects expression | ISO | RGD:1354205 | 6480464 | beta Carotene affects the expression of SPTLC2 mRNA | CTD | PMID:17034753 |
| calcitriol | increases expression | ISO | RGD:1354205 | 6480464 | Calcitriol results in increased expression of SPTLC2 mRNA | CTD | PMID:16002434 |
| choline | multiple interactions | ISO | RGD:1614415 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPTLC2 mRNA | CTD | PMID:20938992 |
| cisplatin | affects response to substance | ISO | RGD:1354205 | 6480464 | SPTLC2 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 |
| cobalt dichloride | increases expression | ISO | RGD:1354205 | 6480464 | cobaltous chloride results in increased expression of SPTLC2 mRNA | CTD | PMID:19376846 |
| cyclosporin A | increases expression | ISO | RGD:1354205 | 6480464 | Cyclosporine results in increased expression of SPTLC2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1614415 | 6480464 | Cyclosporine results in decreased expression of SPTLC2 mRNA | CTD | PMID:19770486 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:1354205 | 6480464 | Tetrahydrocannabinol results in increased expression of SPTLC2 mRNA | CTD | PMID:18163980 |
| diarsenic trioxide | increases expression | ISO | RGD:1354205 | 6480464 | arsenic trioxide results in increased expression of SPTLC2 mRNA | CTD | PMID:20458559 |
| diazoxide | increases expression | ISO | RGD:1614415 | 6480464 | Isoproterenol results in increased expression of SPTLC2 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SPTLC2 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | ISO | RGD:1614415 | 6480464 | Diethylstilbestrol results in increased expression of SPTLC2 mRNA | CTD | PMID:15289156 |
| folic acid | multiple interactions | ISO | RGD:1614415 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPTLC2 mRNA | CTD | PMID:20938992 |
| genistein | increases expression | ISO | RGD:1614415 | 6480464 | Genistein results in increased expression of SPTLC2 mRNA | CTD | PMID:15289156 |
| isoprenaline | increases expression | ISO | RGD:1614415 | 6480464 | Isoproterenol results in increased expression of SPTLC2 mRNA | CTD | PMID:20003209 |
| L-methionine | multiple interactions | ISO | RGD:1614415 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPTLC2 mRNA | CTD | PMID:20938992 |
| methotrexate | affects expression | ISO | RGD:1614415 | 6480464 | Methotrexate affects the expression of SPTLC2 mRNA | CTD | PMID:18502557 |
| paracetamol | affects expression | ISO | RGD:1614415 | 6480464 | Acetaminophen affects the expression of SPTLC2 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1354205 | 6480464 | Acetaminophen results in increased expression of SPTLC2 mRNA | CTD | PMID:21420995 |
| phenobarbital | multiple interactions | ISO | RGD:1614415 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SPTLC2 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:1614415 | 6480464 | Phenobarbital results in increased expression of SPTLC2 mRNA | CTD | PMID:19482888 |
| pirinixic acid | increases expression | ISO | RGD:1614415 | 6480464 | pirinixic acid results in increased expression of SPTLC2 mRNA | CTD | PMID:17426115 PMID:18301758 |
| pirinixic acid | increases expression | ISO | RGD:1614415 | 6480464 | pirinixic acid results in increased expression of SPTLC2 mRNA | CTD | PMID:18301758 PMID:17426115 |
| piroxicam | decreases expression | ISO | RGD:1354205 | 6480464 | Piroxicam results in decreased expression of SPTLC2 mRNA | CTD | PMID:21858171 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:1354205 | 6480464 | tert-Butylhydroperoxide results in increased expression of SPTLC2 mRNA | CTD | PMID:15336504 |
| valproic acid | increases expression | ISO | RGD:1614415 | 6480464 | Valproic Acid results in increased expression of SPTLC2 mRNA | CTD | PMID:21427059 |
| vancomycin | decreases expression | ISO | RGD:1614415 | 6480464 | Vancomycin results in decreased expression of SPTLC2 mRNA | CTD | PMID:18930951 |
| zinc atom | multiple interactions | ISO | RGD:1354205 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SPTLC2 mRNA | CTD | PMID:18593933 |
| zinc(0) | multiple interactions | ISO | RGD:1354205 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of SPTLC2 mRNA | CTD | PMID:18593933 |